Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children’s Oncology Group phase III study AALL0433

Outcomes after relapse of childhood B-acute lymphoblastic leukemia (B-ALL) are poor, and optimal therapy is unclear. The children’s Oncology Group study AALL0433 evaluated a new platform for relapsed ALL. Between March 2007 and October 2013 AALL0433 enrolled 275 participants with late bone marrow or...

Descripción completa

Detalles Bibliográficos
Autores principales: Lew, Glen, Chen, Yichen, Lu, Xiaomin, Rheingold, Susan R., Whitlock, James A., Devidas, Meenakshi, Hastings, Caroline A., Winick, Naomi J., Carroll, William L., Wood, Brent L., Borowitz, Michael J., Pulsipher, Michael A., Hunger, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776266/
https://www.ncbi.nlm.nih.gov/pubmed/32001530
http://dx.doi.org/10.3324/haematol.2019.237230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776266/
https://www.ncbi.nlm.nih.gov/pubmed/32001530
http://dx.doi.org/10.3324/haematol.2019.237230

Ejemplares similares